| Literature DB >> 27430485 |
Shamsudeen F Fagbo1, Musa A Garbati1, Rami Hasan1, Dayel AlShahrani1, Mohamed Al-Shehri1, Tariq AlFawaz1, Ahmed Hakawi1, Tariq Ahmad Wani1, Leila Skakni1.
Abstract
The emergence of the Middle East Respiratory Syndrome (MERS) in Saudi Arabia has intensified focus on Acute Respiratory Infections [ARIs]. This study sought to identify respiratory viruses (RVs) associated with ARIs in children presenting at a tertiary hospital. Children (aged ≤13) presenting with ARI between January 2012 and December 2013 tested for 15 RVs using the SeeplexR RV15 kit were retrospectively included. Epidemiological data was retrieved from patient records. Of the 2235 children tested, 61.5% were ≤1 year with a male: female ratio of 3:2. Viruses were detected in 1364 (61.02%) children, 233 (10.4%) having dual infections: these viruses include respiratory syncytial virus (RSV) (24%), human rhinovirus (hRV) (19.7%), adenovirus (5.7%), influenza virus (5.3%), and parainfluenzavirus-3 (4.6%). Children, aged 9-11 months, were most infected (60.9%). Lower respiratory tract infections (55.4%) were significantly more than upper respiratory tract infection (45.3%) (P < 0.001). Seasonal variation of RV was directly and inversely proportional to relative humidity and temperature, respectively, for non MERS coronaviruses (NL63, 229E, and OC43). The study confirms community-acquired RV associated with ARI in children and suggests modulating roles for abiotic factors in RV epidemiology. However, community-based studies are needed to elucidate how these factors locally influence RV epidemiology. J. Med. Virol. 89:195-201, 2017.Entities:
Keywords: MERS-CoV; acute respiratory illness; multiplex molecular testing platform; pediatrics; respiratory viruses; season
Mesh:
Year: 2016 PMID: 27430485 PMCID: PMC7166860 DOI: 10.1002/jmv.24632
Source DB: PubMed Journal: J Med Virol ISSN: 0146-6615 Impact factor: 2.327
Virus Detection Rate Per Age‐Group, Respiratory Tract Site, and Diseases in Children With ARIs (2012 and 2013)
| Patients | Total | Positive (N/%) |
|
|---|---|---|---|
| Female | 931 (41.7) | 567 (60.9) | 0.917 |
| Male | 1304 (58.3) | 797 (61.1) | |
| Upper respiratory tract | 1202 (53.8) | 666 (55.4) | <0.001 |
| Lower respiratory tract | 1033 (46.2) | 698 (67.6) | |
| 0 month | 288 (12.9) | 157 (54.5) | 0.015 |
| 1 month | 208 (9.3) | 126 (60.6) | 0.888 |
| 2 months | 202 (9.0) | 140 (69.3) | 0.011 |
| 3–5 months | 336 (15.0) | 219 (65.2) | 0.091 |
| 6–8 months | 207 (9.3) | 134 (64.7) | 0.251 |
| 9–11 months | 133 (6.0) | 100 (75.2) | 0.001 |
| 1–5 years | 673 (30.1) | 396 (58.8) | 0.164 |
| 6–12 years | 188 (8.4) | 92 (48.9) | <0.001 |
| Bronchiolitis and pneumonia | 841 (37.6) | 590 (70.2) | <0.001 |
Respiratory Viruses Detected, According to Age Group Between 2012 and 2013
| Virus | <1 m, no (%) | 1–<2 m, no (%) | 2–<3 m, no (%) | 3–<6 m, no (%) | 6–<9 m, no (%) | 9–<12 m, no (%) | 1–<6 y, no (%) | 6–<13 y, no (%) | Total |
|
|---|---|---|---|---|---|---|---|---|---|---|
| ADV | 2 (0.7) | 2 (1.0) | 6 (3.0) | 28 (8.3) | 19 (9.2) | 10 (7.5) | 53 (7.9) | 7 (3.7) | 127 (5.7) | <0.001 |
| hBoV | 0 (0.0) | 1 (0.5) | 1 (0.5) | 6 (1.8) | 7 (3.4) | 3 (2.3) | 15 (2.2) | 1 (0.5) | 34 (1.5) | 0.023 |
| NL63/229E/OC43 | 13 (4.5) | 5 (2.4) | 11 (5.5) | 11 (3.3) | 7 (3.4) | 7 (5.3) | 16 (2.4) | 7 (3.7) | 77 (3.4) | 0.35 |
| hEV | 3 (1.0) | 4 (1.9) | 5 (2.5) | 4 (1.2) | 1 (0.5) | 1 (0.8) | 17 (2.5) | 1 (0.5) | 36 (1.6) | 0.234 |
| IFLA | 4 (1.4) | 3 (1.4) | 4 (2.0) | 11 (3.3) | 7 (3.4) | 6 (4.5) | 29 (4.3) | 9 (4.8) | 73 (3.3) | 0.147 |
| IFLB | 2 (0.7) | 3 (1.4) | 1 (0.5) | 4 (1.2) | 3 (1.4) | 2 (1.5) | 20 (3.0) | 10 (5.3) | 45 (2) | 0.005 |
| hMPV | 6 (2.1) | 2 (1.0) | 10 (5.0) | 17 (5.1) | 13 (6.3) | 10 (7.5) | 32 (4.8) | 4 (2.1) | 94 (4.2) | 0.012 |
| PIV1 | 0 (0.0) | 3 (1.4) | 3 (1.5) | 5 (1.5) | 3 (1.4) | 5 (3.8) | 16 (2.4) | 2 (1.1) | 37 (1.7) | 0.129 |
| PIV2 | 1 (0.3) | 0 (0.0) | 2 (1.0) | 5 (1.5) | 1 (0.5) | 2 (1.5) | 9 (1.3) | 7 (3.7) | 27 (1.2) | 0.028 |
| PIV3 | 8 (2.8) | 11 (5.3) | 11 (5.4) | 18 (5.4) | 9 (4.3) | 3 (2.3) | 37 (5.5) | 6 (3.2) | 103 (4.6) | 0.435 |
| PIV4 | 5 (1.7) | 0 (0.0) | 3 (1.5) | 1 (0.3) | 2 (1.0) | 2 (1.5) | 5 (0.7) | 2 (1.1) | 20 (0.9) | 0.416 |
| hRV | 50 (17.4) | 44 (21.2) | 61 (30.2) | 63 (18.8) | 44 (21.3) | 30 (22.6) | 116 (17.2) | 32 (17.0) | 440 (19.7) | 0.006 |
| RSV A | 55 (19.1) | 51 (24.5) | 46 (22.8) | 74 (22.0) | 36 (17.4) | 25 (18.8) | 83 (12.3) | 11 (5.9) | 381 (17) | <0.001 |
| RSV B | 29 (10.1) | 14 (6.7) | 9 (4.5) | 15 (4.5) | 13 (6.3) | 14 (10.5) | 35 (5.2) | 2 (1.1) | 131 (5.9) | <0.001 |
m, month; y, year.
Figure 1Co‐infection pattern in respiratory viruses detected in children tested.
Figure 2Frequency of detection of respiratory viruses detected in children tested.
Figure 3A: Seasonal variation of hRV, RSV, and hMPV viruses. B: Pattern of RSV A and B detection.
Figure 4Temporal correlation of respiratory virus detection with weather station documented average humidity (A) and temperature, (B) 2012–2013.